PRESS RELEASE published on 12/05/2023 at 14:00, 2 years 10 months ago Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day Salix Pharmaceuticals, Bausch Health Companies Inc., U.S. Pain Foundation, and IFFGD collaborate to establish the first annual Opioid-Induced Constipation (OIC) Awareness Day to raise awareness about the often-overlooked side effect of opioids and provide a platform for patients, caregivers, and healthcare providers to discuss and address OIC Healthcare Providers Chronic Pain Opioid-Induced Constipation Awareness Day Patient Advocacy
PRESS RELEASE published on 11/10/2023 at 14:00, 2 years 11 months ago The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
PRESS RELEASE published on 11/10/2023 at 06:00, 2 years 11 months ago CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
PRESS RELEASE published on 11/08/2023 at 14:00, 2 years 11 months ago As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 11/02/2023 at 12:00, 2 years 11 months ago Bausch Health Announces Third-Quarter 2023 Results
PRESS RELEASE published on 11/01/2023 at 17:22, 2 years 11 months ago U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
PRESS RELEASE published on 10/26/2023 at 14:00, 2 years 11 months ago Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 10/20/2023 at 23:20, 2 years 11 months ago FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 11 months ago New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
PRESS RELEASE published on 10/12/2023 at 14:00, 3 years ago Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
Published on 10/15/2026 at 16:10, 2 hours 6 minutes ago North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 3 hours 1 minute ago Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 3 hours 45 minutes ago First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 4 hours 11 minutes ago Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 14:00, 4 hours 16 minutes ago Tectonic Metals Drills 2.41 g/t Au over 59.44 metres, Including 11.82 g/t Au over 10.67 metres and 39.96 g/t Au over 3.05 metres at Alpha Bowl, Flat Gold Project, Alaska
Published on 10/15/2026 at 18:03, 13 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:00, 16 minutes ago Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract
Published on 10/15/2026 at 18:00, 16 minutes ago EQS-Adhoc: AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 16:55, 1 hour 20 minutes ago Verlingue consolidates its international offering by integrating Verlingue Portugal into the WBN network
Published on 10/15/2026 at 07:27, 10 hours 48 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
Published on 10/14/2026 at 18:00, 1 day ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.